Christian Yavorsky

Christian Yavorsky is a prominent figure in the fields of neuropsychology and clinical trials methodology. He currently serves as an Advisor at TRIPP, an innovative company focused on adaptive digiceuticals and immersive wellness solutions. In addition to his advisory role at TRIPP, he is the Co-founder and Chief Scientific Officer of Valis Bioscience, where he oversees various scientific and research programs related to neuroscience.1

Educational Background

Yavorsky holds a Bachelor's Degree in Physiological Psychology/Psychobiology from George Mason University, which he completed from 1991 to 1995. He furthered his education with a Master's Degree in Psychology from The University of Sheffield (1997-1999) and obtained a Ph.D. in Psychology from The Manchester Metropolitan University (1999-2003) .1

Professional Experience

Yavorsky has extensive experience in clinical trials, having participated in over 60 Phase I-IV trials. His career includes significant roles such as:

• Senior Rater Manager at Medavante
• Research Director at ProPhase
• Chief Scientific Officer at Cronos CCS
• Consultant Senior Scientist at The Nathan Kline Institute.12

His work primarily focuses on developing processes and tools aimed at enhancing the reliability of outcome measures in clinical trials, particularly in developing countries.

Contributions to Science

Dr. Yavorsky is recognized for his contributions to the advancement of clinical trial methodologies and has lectured globally on these topics. His commitment to improving clinical trial processes reflects his broader interest in addressing systemic challenges within the field.1